Washington, DC, April 20, 2017 – Friends of Cancer Research (Friends) Chairperson & Founder, Ellen V. Sigal, will receive the Face of Hope award at LUNGevity’s Celebration of Hope event tomorrow evening. The Face of Hope award is presented to an individual who recognizes the needs of those living with lung cancer and is actively making a difference.
“All of us at Friends are extremely proud of Ellen’s accomplishments and we are thrilled that she is receiving this recognition from our great partners at LUNGevity,” said Friends’ President & CEO, Jeff Allen. “Ellen works tirelessly for those impacted by cancer and her efforts enact meaningful change. It is her dedication that inspires us at Friends.”
Sigal founded Friends more than 20 years ago to bring together leaders from every healthcare sector to power advances in science policy and regulation to help speed lifesaving treatments to patients. She is Vice Chair, and currently Acting Chair, of the inaugural board of directors of the Reagan-Udall Foundation; serves on the Board of the Foundation for the National Institutes of Health, where she chairs its Public Private Partnerships Committee; and in 2010 was appointed to the inaugural Board of Governors of the Patient Centered Outcomes Research Institute. Last year, Sigal was named to former Vice President Biden’s Cancer Moonshot Blue Ribbon Panel, to the Parker Institute for Immunotherapy Advisory Group, and joined the inaugural board of advisors for the George Washington University’s Milken Institute of Public Health.
The 6th Annual LUNGevity Celebration of Hope spotlights the unprecedented progress in lung cancer research that is giving survivors more reason for hope than ever before with the opportunity to celebrate.
For more information on the event, please visit: https://www.lungevity.org/events/galas-special-events/musical-celebrati….
For any media interested in covering the event, please contact Linda Wenger at (973) 449-3214; or via email at lwenger@LUNGevity.org.
About Friends of Cancer Research
Friends of Cancer Research (Friends) drives collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed lifesaving treatments to patients. For more information, please visit www.focr.org.
